Preparation and characterization of paclitaxel delivery system based on semi-solid lipid nanoparticles coated with poly (ethylene glycol)

Pharmazie

Volumn 65, Issue 7, 2010, Pages 493-499

  Wu, Lifang ^a   Tang, Cui ^a   Yin, Chunhua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; NANOCARRIER; PACLITAXEL; SEMI SOLID LIPID NANOPARTICLE; TREHALOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG UPTAKE; MATERIAL COATING; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENOUS; LIPIDS; MACROPHAGES, PERITONEAL; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; PHAGOCYTOSIS; PHARMACEUTIC AIDS; POLYETHYLENE GLYCOLS; SOLUBILITY; TISSUE DISTRIBUTION;

EID: 77955379219     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9341     Document Type: Article

References (33)

1. Allen TM (1994) The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Del Rev 13: 285-309.
2. Ana V, Howard G, Orla M, María JA(2004) Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 98: 231-244.
3. Aramaki Y, Akiyama K, Hara T, Tsuchiya SS (1995) Recognition of charged liposomes by rat peritoneal and splenic macrophages: effects of fibronectin on the uptake of charged liposomes. Eur J Pharm Sci 3: 63-70.
4. Bocca C, Caputo O, Cavalli R, Gabriel L, Miglietta A, Gasco MR (1998) Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int J Pharm 175: 185-193.
5. Chen DB,Yang TZ, Lv WL, ZhangQ(2002) In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel. Acta Pharm Sin 37: 54-58.
6. Dubernet C (1995) Thermoanalysis of microspheres. Thermochim Acta 248: 259-269.
7. Evora C, Soriano I, Rogers RA, Shakesheff KM, Hanes J, Langer R (1998) Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosadhesion phatidylcholine. J Control Release 51: 143-152.
8. Freitas C, Müller RH (1998) Spray-drying of solid lipid nanoparticles (SLN™). Eur J Pharm Biopharm 46: 145-151.
9. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987-992.
10. Garcia-Fuentes M, Alonso MJ, Torres D (2005) Design and characterization of a newdrug nanocarrier made from solid - liquid lipid mixtures. J Colloid Interface Sci 285: 590-598.
11. Gradishar WJ (2006) Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7: 1041-1053.
12. Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil - based paclitaxel in women with breast Cancer. J Clin Oncol 23: 7794-7803.
13. Heiati H, Tawashi R, Phillips NC (1998) Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilisation. J Microencaps 15: 173-184.
14. Jenning V, Thünemann AF, Gohla SH (2000) Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199: 167-177.
15. Klivanov AL, Maruyama K, Beckerley AM, Torchilin VP, Huang L (1991) Activity of amphipathic poly (ethylene glycol) 5 000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposomes binding to target. Biochim Biophys Acta 1062: 142-148.
16. Lamprecht A, Bouligand Y, Benoit JP (2002) New lipid nanocapsules exhibit sustained release properties for amiodarone. J Control Release 84: 59-68.
17. Lifang Wu, Cui Tang, Chunhua Yin (2009) Folate-mediated solid-liquid lipid nanoparticles for paclitaxel coated poly(ethylene glycol). Drug Devel Ind Pharm, doi 10.3109/03639040903244472.
18. Liggins RT, Hunter WL, Burt HM (1997) Solid-state characterization of paclitaxel. J Pharm Sci 12: 1458-1463.
19. Muhlen A, Schwarz C, Mehnert W (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release mechanism. Eur J Pharm Biopharm 45: 149.
20. Mehnert W, Mader K (2001) Solid lipid nanoparticles: production, characterization and applications. Advanced. Drug Del Rev 47: 165-196.
21. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 50: 161-177.
22. Prior S, Gander B, Blarer N, Merkle HP, Subira ML, Irache JM, Gamazo V (2002) In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci 15: 197-207.
23. Rudt S, Müller RH (1992) In vitro phagocytosis assay of nano- and microparticles by chemiluminiscence. I: Effect of analytical parameters, particle size and particle concentration. J Control Release 22: 263-272.
24. Sahoo SK, Ma W, Labhasetwar V (2004) Efficacy of transferring conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 112: 335-340.
25. Schwarz C, Mehnert W, Müller RH (1994) Lyophilization of solid lipid nanoparticles (SLN). Eur J Pharm Sci 2: 177.
26. Schwarz C, Mehnert W (1997) Free-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 157: 171-179.
27. Song D, Hsu LF, Au JLS (1996) Binding of paclitaxel to plastic glass container and protein under in vitro conditions. J Pharm Sci 85: 29-31.
28. Spencer CM, Faulds D (1994) Paclitaxel. Drugs 48: 794-847.
29. Szebeni J, Muggia FM, Alving CR (1998) Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J National Cancer Institute 90: 300-306.
30. Westesen K, Bunjes H, Koch MHJ (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48: 223-236.
31. Woodle MC, Lasic DD (1992) Sterically stabilized liposomes. Biochim Biophys Acta 1113: 171-199.
32. Zara GP, Cavalli R, Bargoni A, Fundarò A, Vighetto D, Gasco MR (2002) Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded Solid Lipid Nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target 10: 327-335.
33. Zhang ZP, Feng SS (2006) The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide) - tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27: 4025-4033.